![Ruti-Alon_150x200-1[1]](https://kenes-exhibitions.com/biomed2023/wp-content/uploads/elementor/thumbs/Ruti-Alon_150x200-11-pxsgcipwuxa3vzcw5ps3gu4pkhl01q3pabyr93tq0w.jpg "Ruti-Alon_150x200-1[1]")
![Ora-Dar_150x200-1[1]](https://kenes-exhibitions.com/biomed2023/wp-content/uploads/elementor/thumbs/Ora-Dar_150x200-11-pxsgxl9o284i5ar24bo0v0poyfq7lgr36mfljel0jk.jpg "Ora-Dar_150x200-1[1]")
![Nissim-Darvish_150x200-1[1]](https://kenes-exhibitions.com/biomed2023/wp-content/uploads/elementor/thumbs/Nissim-Darvish_150x200-11-pxsh1381i0wxd1o3ou4154xgk2he8wn4bxunuhe9ds.jpg "Nissim-Darvish_150x200-1[1]")
Conference Moderators
Abraham Accords Healthcare Collaboration and Innovation
Susan K. Finston, JD/MPP
Senior Advisor, President
Princeton Capital Advisors, Finston Consulting LLC
Are recent trends reshuffling MedTech companies value capture towards data, digital and commercialization elements?
Arjun (JJ) Desai, MD
CSIO
INSIGHTEC
Read More
Are recent trends reshuffling MedTech companies value capture towards data, digital and commercialization elements?
Gilad Glick, MBA
VP JJDC MedTech, Growth Stage Executive
Johnson & Johnson Innovation Fund
AI Tapestry: Optimizing the Interaction of AI and Biopharma
How Do We Make Academic Translation Medicine replicable and relevant?
Ophthalmology, from R&D to Commercialization
Prof. Anat Loewenstein, MD
Director, Ophthalmology Division Sidney Fox Chair in Ophthalmology
Sackler Faculty of Medicine, Tel Aviv University President, Israeli Ophthalmological Society
High Pace Innovation in Dermatology & Medical Aesthetics
High Pace Innovation in Dermatology & Medical Aesthetics
Navigating Global Collaborations in Times of Uncertainty: Can we turn challenges into growth opportunities?
Daphna Murwitz, LLB
Co-Founder & CEO
8400 Health Network
Read More
Can we Successfully Diagnose and Guide Patient’s Optimal Cancer Treatment?
Bio Convergence - Everything That Rises Must Converge
Facts and Myths on Ex-Liver Delivery of Nucleic Acid Therapeutics and New Horizons to Cure Rare Disorders
Facts and Myths on Ex-Liver Delivery of Nucleic Acid Therapeutics and New Horizons to Cure Rare Disorders
Let Food be Thy Medicine and Medicine be Thy Food
![Tammy-Meiron_450x600[1]](https://kenes-exhibitions.com/biomed2023/wp-content/uploads/elementor/thumbs/Tammy-Meiron_450x6001-pxst0qnvz3t8yio75f4c67lt62xh129mcextoxds00.jpg "Tammy-Meiron_450x600[1]")
Robots Dancing with Humans in the Healthcare Systems and Homes
Patients are Consumers at Home – How Far Can They Manage Their Health?
AI tapestry: Optimizing the Interaction of AI and Biopharma
Can we Successfully Diagnose and Guide Patients’ Optimal Cancer Treatment?
Are Cancer Therapeutics Fulfilling the Promise?
Do we Know Enough About the Brain to Treat Neurological Disorders?
US Launch Preparation: The Essential Factors for Optimal Reimbursement & Maximum Profitability
Pete Vaccaro, MA
Partner
Formulary Insights
Read More
US Launch Preparation: The Essential Factors for Optimal Reimbursement & Maximum Profitability
Amy Heath, BA, MSM
Partner
Formulary Insights